Repository logo
 
Publication

Bioactivity of different formulations of artichoke and milk thistle, commonly used for hepatoprotective effects

dc.contributor.authorPereira, Carla
dc.contributor.authorBarros, Lillian
dc.contributor.authorFerreira, Isabel C.F.R.
dc.date.accessioned2013-09-09T10:16:01Z
dc.date.available2013-09-09T10:16:01Z
dc.date.issued2013
dc.description.abstractCynara scolymus L. (artichoke) is today widely cultivated all over the world for its large fleshy immature inflorescences and known since ancient times as a tasty plant that can be used in soups, stews and salads, being perceived as a nutritious and healthy vegetable due to its antioxidant and hepatoprotective effects [1]. Silybum marianum (L.) Gaertn (milk thistle) is an hercaceous plant with reported effects against hepatotoxicity and acute and chronic liver diseases, due to its main pharmacological active ingredient silymarin (standard mixture of flavonoligans) that also has antioxidant properties [2,3]. Thus, artichoke and milk thistle are two plants widely used regarding hepatoprotective effects but to the best of our knowledge no antihepatocellular carcinoma activity has been studied, particularly in the most consumed forms: infusions and dietary supplements. In the present work, antioxidant properties (reducing power, radical scavenging activity and lipid peroxidation inhibition), anti-hepatocellular carcinoma activity (HepG2 tumour cell lines) and hepatotoxicity (non-tumour liver primary culture PLP2) of infusions and dietary supplements of the mentioned plants were evaluated and compared. Both plants revealed antioxidant properties with EC50 values lower than the daily recommended dose. The infusions of milk thi stle and artichoke revealed, in general, sim ilar contents in phenolics and antioxidant activity. Artichoke infusion also presented anti-hepatocellular carcinoma activity (GI50 = 52 1-lg/ml) but with some toxicity for normal liver primary cells at concentrations higher than Gl50 = 72 11g/ml. The studied bioactive properties (antioxidant and antitumour) were positively correlated with phenolics and flavonoids content. Regarding dietary supplements, the bioactive compounds amount and antioxidant activity of milk thistle was higher than artichoke's. These samples neither revealed anti-hepatocelullar carcinoma activity, nor toxicity for normal liver cells.por
dc.description.sponsorshipFoundation for Science and Technology (FCT, Portugal) for fin ancial support to the research centre CIMO (PEst-OE/AGR/UI0690/201 1). L. Barros also thanks to FCT, POPH-OREN and FSE for her grant (SFRH/BPD/4609/2008).por
dc.identifier.citationPereira, C.; Barros, Lillian; Ferreira, I.C.F.R. (2013). Bioactivity of different formulations of artichoke and milk thistle, commonly used for hepatoprotective effects. In 1st Symposium on Medicinal Chemistry. Bragapor
dc.identifier.urihttp://hdl.handle.net/10198/8665
dc.language.isoengpor
dc.peerreviewedyespor
dc.relationSFRH/BPD/4609/2008
dc.relationStrategic Project - UI 690 - 2011-2012
dc.titleBioactivity of different formulations of artichoke and milk thistle, commonly used for hepatoprotective effectspor
dc.typeconference object
dspace.entity.typePublication
oaire.awardTitleStrategic Project - UI 690 - 2011-2012
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/PEst-OE%2FAGR%2FUI0690%2F2011/PT
oaire.citation.conferencePlaceBraga, Portugalpor
oaire.citation.title1st Symposium on Medicinal Chemistry of University of Minhopor
oaire.fundingStream6817 - DCRRNI ID
person.familyNamePereira
person.familyNameBarros
person.familyNameFerreira
person.givenNameCarla
person.givenNameLillian
person.givenNameIsabel C.F.R.
person.identifier1415151
person.identifier469085
person.identifier144781
person.identifier.ciencia-idEF10-2739-2B70
person.identifier.ciencia-id9616-35CB-D001
person.identifier.ciencia-id9418-CF95-9919
person.identifier.orcid0000-0003-0093-771X
person.identifier.orcid0000-0002-9050-5189
person.identifier.orcid0000-0003-4910-4882
person.identifier.ridK-1629-2016
person.identifier.ridJ-3600-2013
person.identifier.ridE-8500-2013
person.identifier.scopus-author-id55627876424
person.identifier.scopus-author-id35236343600
person.identifier.scopus-author-id36868826600
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspor
rcaap.typeconferenceObjectpor
relation.isAuthorOfPublicatione07a8e12-52bb-47c5-bae7-41a5f648213b
relation.isAuthorOfPublication3af07ffe-f914-48ba-a5d5-efcf70fdce01
relation.isAuthorOfPublicationbd0d1537-2e03-41fb-b27a-140af9c35db8
relation.isAuthorOfPublication.latestForDiscoverybd0d1537-2e03-41fb-b27a-140af9c35db8
relation.isProjectOfPublicationc59f09d4-9931-4f2e-babb-ef8bed998be7
relation.isProjectOfPublication.latestForDiscoveryc59f09d4-9931-4f2e-babb-ef8bed998be7

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Poster Nac. 131.pdf
Size:
457.8 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: